FDA Inspection 696483 — Cascadia Manufacturing Inc

Cascadia Manufacturing Inc — FEI 3005105463

The FDA completed an inspection of Cascadia Manufacturing Inc on November 16, 2010 in Bellevue, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 24 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 16, 2010
Fiscal Year
2011
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Bellevue, WA (United States)

Citations

IDCFRDescription
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
135821 CFR 211.100(b)SOPs not followed / documented
139521 CFR 211.103Actual vs. theoretical yields not determined
163321 CFR 211.130(d)Examination of packaging and labeling
176721 CFR 211.137(a)Expiration date lacking
184921 CFR 211.84(d)(6)Objectionable microbiological contamination
188321 CFR 211.165(a)Testing and release for distribution
188621 CFR 211.165(c)Sampling and testing plans not described
200421 CFR 211.184(d)Labeling: documentation of exam and review
202621 CFR 211.192Quality control unit review of records
202821 CFR 211.192Extent of discrepancy, failure investigations
344521 CFR 211.65(a)Equipment construction - reactive surfaces
355721 CFR 211.52Washing and toilet facilities are deficient
358321 CFR 211.110(a)Written in-process control procedures
360321 CFR 211.160(b)Scientifically sound laboratory controls
361621 CFR 211.165(d)Acceptance criteria for sampling & testing
363921 CFR 211.204Returned drug procedures in writing and followed
430321 CFR 211.67(b)Written procedures fail to include
430621 CFR 211.80(a)Written Procedures Not Followed
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
438921 CFR 211.198(a)Procedures to be written and followed
439921 CFR 211.186(b)(7)Theoretical yield statement including percentages